Table 5 The information of 12 lncRNAs positively validated in the expanding cohort in present study and their potential orthologous sequences comparing with mouse data.

From: LncRNA LYPLAL1-DT screening from type 2 diabetes with macrovascular complication contributes protective effects on human umbilical vein endothelial cells via regulating the miR-204-5p/SIRT1 axis

LncRNA

Novel/known

The log2 value in the RNA-seq data

Orthologous sequence with mouse

ENSG00000269902

known

−2.81

Not found

ENSG00000224307

known

2.17

Not found

ENSG00000228063

known

−1.22

Not found

MSTRG.122492

novel

−3.65

chr3:58,478,307-58,478,532

MSTRG.74858

novel

−3.77

chr11:121,806,938-121,808,036

MSTRG.95088

novel

−6.19

chr2:45,237,395-45,239,069

MSTRG.159327

novel

1.81

chr5:143,473,978-143,503,553

MSTRG.30000

novel

1.69

chr2:91,023,089-91,023,445

MSTRG.131944

novel

−1.56

chr3:136,106,245-136,114,883

MSTRG.152898

novel

2.91

Not found

MSTRG.63013

novel

1.73

chr17:23,644,824-23,660,240

MSTRG.3528

novel

2.64

chr4:118,424,930-118,425,109